Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

The Proteome of Primary Prostate Cancer

Iglesias-Gato, Diego, Wikström, Pernilla, Tyanova, Stefka, Lavallee, Charlotte, Thysell, Elin, Carlsson, Jessica, Hägglöf, Christina, Cox, Jürgen, Andrén, Ove, Stattin, Pär, Egevad, Lars, Widmark, Anders, Bjartell, Anders, Collins, Colin C., Bergh, Anders, Geiger, Tamar, Mann, Matthias, Flores-Morales, Amilcar · 2016 · European Urology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2015.10.053

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 39

  1. Siegel, 2014, Cancer statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208 · DOI · Paper page
  2. Rider, 2013, Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study, Eur Urol, 63, 88, 10.1016/j.eururo.2012.08.001 · DOI · Paper page
  3. Loeb, 2013, Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer, J Urol, 190, 1742, 10.1016/j.juro.2013.05.054 · DOI
  4. Barbieri, 2012, Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer, Nat Genet, 44, 685, 10.1038/ng.2279 · DOI · Paper page
  5. Taylor, 2010, Integrative genomic profiling of human prostate cancer, Cancer Cell, 18, 11, 10.1016/j.ccr.2010.05.026 · DOI · Paper page
  6. Geiger, 2010, Super-SILAC mix for quantitative proteomics of human tumor tissue, Nat Methods, 7, 383, 10.1038/nmeth.1446 · DOI · Paper page
  7. Ostasiewicz, 2010, Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry, J Proteome Res, 9, 3688, 10.1021/pr100234w · DOI · Paper page
  8. Cox, 2011, Andromeda: a peptide search engine integrated into the MaxQuant environment, J Proteome Res, 10, 1794, 10.1021/pr101065j · DOI · Paper page
  9. Josefsson, 2012, Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance, Scand J Urol Nephrol, 46, 247, 10.3109/00365599.2012.669791 · doi:10.3109/00365599.2012.669791
  10. Andren, 2006, How well does the Gleason score predict prostate cancer death?. A 20-year followup of a population based cohort in Sweden, J Urol, 175, 1337, 10.1016/S0022-5347(05)00734-2 · DOI · Paper page
  11. Ahlqvist, 2013, Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer, Oncogene, 32, 1601, 10.1038/onc.2012.175 · DOI
  12. Whitaker-Menezes, 2011, Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue, Cell Cycle, 10, 4047, 10.4161/cc.10.23.18151 · DOI · Paper page
  13. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  14. Kobayashi, 2011, DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer, Genome Res, 21, 1017, 10.1101/gr.119487.110 · DOI · Paper page
  15. Lindberg, 2013, The mitochondrial and autosomal mutation landscapes of prostate cancer, Eur Urol, 63, 702, 10.1016/j.eururo.2012.11.053 · DOI
  16. Costello, 1989, Prostate epithelial cells utilize glucose and aspartate as the carbon sources for net citrate production, Prostate, 15, 335, 10.1002/pros.2990150406 · doi:10.1002/pros.2990150406
  17. Leiblich, 2006, Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer, Oncogene, 25, 2953, 10.1038/sj.onc.1209262 · DOI
  18. Egevad, 2002, Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection, J Urol, 168, 509, 10.1016/S0022-5347(05)64669-1 · doi:10.1016/s0022-5347(05)64669-1
  19. Stark, 2009, Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?, J Clin Oncol, 27, 3459, 10.1200/JCO.2008.20.4669 · DOI · Paper page
  20. Bostwick, 1998, Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases, Cancer, 82, 2256, 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S · DOI · Paper page
  21. Hagglof, 2012, The stroma-a key regulator in prostate function and malignancy, Cancers (Basel), 4, 531, 10.3390/cancers4020531 · DOI
  22. Rasiah, 2006, Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis, Cancer Epidemiol Biomarkers Prev, 15, 711, 10.1158/1055-9965.EPI-05-0752 · DOI
  23. Funkelstein, 2008, Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression, J Neurochem, 106, 384, 10.1111/j.1471-4159.2008.05408.x · doi:10.1111/j.1471-4159.2008.05408.x
  24. Massoner, 2013, Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y, PloS One, 8, e55207, 10.1371/journal.pone.0055207 · DOI
  25. Hagglof, 2014, TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers, PloS One, 9, e86824, 10.1371/journal.pone.0086824 · DOI
  26. Tan, 2014, Evaluation of ERG responsive proteome in prostate cancer, Prostate, 74, 70, 10.1002/pros.22731 · DOI
  27. Tomlins, 2007, Integrative molecular concept modeling of prostate cancer progression, Nat Genet, 39, 41, 10.1038/ng1935 · DOI · Paper page
  28. Chuan, 2010, Ezrin mediates c-Myc actions in prostate cancer cell invasion, Oncogene, 29, 1531, 10.1038/onc.2009.442 · DOI
  29. Tennakoon, 2014, Androgens regulate prostate cancer cell growth via an AMPK-PGC-1alpha-mediated metabolic switch, Oncogene, 33, 5251, 10.1038/onc.2013.463 · DOI · Paper page
  30. Rambold, 2011, Mechanisms of mitochondria and autophagy crosstalk, Cell Cycle, 10, 4032, 10.4161/cc.10.23.18384 · DOI · Paper page
  31. Mao, 1966, Human prostatic carcinoma: an electron microscope study, Cancer Res, 26, 955
  32. Movsas, 2000, Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study, Cancer, 89, 2018, 10.1002/1097-0142(20001101)89:9<2018::AID-CNCR19>3.0.CO;2-Y · DOI
  33. Margel, 2013, Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes, J Clin Oncol, 31, 3069, 10.1200/JCO.2012.46.7043 · DOI · Paper page
  34. Egevad, 2002, Prognostic value of the Gleason score in prostate cancer, BJU Int, 89, 538, 10.1046/j.1464-410X.2002.02669.x · doi:10.1046/j.1464-410x.2002.02669.x
  35. Ueda, 2013, Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide, J Proteome Res, 12, 4497, 10.1021/pr400547s · doi:10.1021/pr400547s
  36. Nagakawa, 2001, Effect of prostatic neuropeptides on migration of prostate cancer cell lines, Int J Urol, 8, 65, 10.1046/j.1442-2042.2001.00250.x · DOI
  37. Ruscica, 2006, Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells, Endocrinology, 147, 1466, 10.1210/en.2005-0925 · doi:10.1210/en.2005-0925
  38. Allen, 2011, Neuropeptide Y acts within the rat testis to inhibit testosterone secretion, Neuropeptides, 45, 55, 10.1016/j.npep.2010.10.006 · DOI
  39. Kitlinska, 2005, Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors, Cancer Res, 65, 1719, 10.1158/0008-5472.CAN-04-2192 · DOI

Cited by

See all 163

Metadata

Authors
Iglesias-Gato, D., Wikström, P., Tyanova, S., Lavallee, C., Thysell, E., Carlsson, J., Hägglöf, C., Cox, J., Andrén, O., Stattin, P., Egevad, L., Widmark, A., Bjartell, A., Collins, C. C., Bergh, A., Geiger, T., Mann, M., & Flores-Morales, A.
Venue
European Urology
Publisher
Elsevier BV
Published
2016-05
Volume
69
Issue
5
Pages
942-952
ISSN
0302-2838 (ISSN-L)
OpenAlex
W2183117764
Cited by
163
References
11
FWCI
7.37
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Proteome of Primary Prostate Cancer. https://app.cochat.ai/papers/10.1016/j.eururo.2015.10.053
The paper
Iglesias-Gato, D., Wikström, P., Tyanova, S., Lavallee, C., Thysell, E., Carlsson, J., Hägglöf, C., Cox, J., Andrén, O., Stattin, P., Egevad, L., Widmark, A., Bjartell, A., Collins, C. C., Bergh, A., Geiger, T., Mann, M., & Flores-Morales, A. (2016). The Proteome of Primary Prostate Cancer. European Urology. https://doi.org/10.1016/j.eururo.2015.10.053

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.